Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 13/20 | 0.37 |
| ▸ | PGR | P06401 | 4/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21898722 | 0.97 | AR (0.37) | ARPGRCYP11B1CYP11B2TRPA1 | |
| SCHEMBL21898727 | 0.93 | AR (0.38) | ARPGRCYP11B1CYP11B2TRPA1 | |
| SCHEMBL21898721 | 0.92 | AR (0.38) | ARPGRCYP11B1CYP11B2KDM4E | |
| SCHEMBL21898724 | 0.91 | AR (0.37) | ARPGRTRPA1 | |
| SCHEMBL20616947 | 0.90 | AR (0.44) | ARPGRTRPA1 | |
| SCHEMBL21898524 | 0.90 | AR (0.37) | ARPGRTRPA1EGLN2 | |
| SCHEMBL20623782 | 0.89 | AR (0.41) | ARPGRTRPA1RXRARXRG | |
| SCHEMBL21898702 | 0.89 | AR (0.45) | ARPGRTRPA1 | |
| SCHEMBL20624366 | 0.88 | KIF11 (0.41) | ARPGREGLN2 | |
| SCHEMBL20623784 | 0.88 | KIF11 (0.39) | ARTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661412-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-30 | — | — | US | disclosed |
| US-20200123131-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123131-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, AOC3, MT-CO3 | AR 4468/4885PGR 3332/4885CYP11B1 1096/4885 |
| US-11661412-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, AOX1 | AR 4596/4885PGR 3430/4885CYP11B1 1130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.